Pneumococcal disease

Latest updates

News

Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children

news -

Peer-Reviewed Publication

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: An observational multicentre study

2017

Data

Figure 2. Number of reported confirmed cases of invasive pneumococcal disease per 100 000 population, EU/EEA, 2014

map -

Data

Figure 4. Seasonal distribution of reported confirmed cases of invasive pneumococcal disease, EU/EEA, 2014 compared with 2010−2013

graph -

Peer-Reviewed Publication

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: An observational multicentre study

2017

Publication

Invasive pneumococcal disease - Annual Epidemiological Report 2016 [2014 data]

surveillance report -

Publication

External quality assessment scheme for Streptococcus pneumoniae – 2014

technical report, external quality assessment -

Publication

Surveillance of invasive bacterial diseases in Europe, 2012

surveillance report -

News

Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children

news -

News

Surveillance of invasive bacterial diseases in Europe 2010 and 2011

news -

News

Surveillance of invasive pneumococcal disease in Europe

news -

News

Decline in early childhood respiratory tract infections in the norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination

ECDC comment -
There are currently no items to display

Data

Figure 2. Number of reported confirmed cases of invasive pneumococcal disease per 100 000 population, EU/EEA, 2014

map -

Data

Figure 4. Seasonal distribution of reported confirmed cases of invasive pneumococcal disease, EU/EEA, 2014 compared with 2010−2013

graph -

Data

Figure 6. Distribution of confirmed cases of invasive pneumococcal disease: most common serotypes in 2014 (n=12 980), 2013 (n=14 811) and 2012 (n=14 845)

graph -

Data

Figure 7. Invasive pneumococcal disease, reported, confirmed cases aged <5 years: serotype distribution by PCV vaccine type, 2011–2014 (n= 4 783)

graph -

Related content

Vaccine-preventable diseases

2009 influenza A (H1N1) pandemic

Disease / public health area

Cholera

Disease / public health area

Congenital rubella syndrome (CRS)

Disease / public health area

Diphtheria

Disease / public health area

Hepatitis B

Disease programmes and networks

European Invasive Bacterial Disease Surveillance Network (EU-IBD)

Vaccine-preventable Diseases Programme

Eurosurveillance

12 March 2015 - Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012
19 February 2015 - Comparative safety evaluation of 7-valent and 13-valent pneumococcal vaccines in routine paediatric vaccinations in four Italian regions, 2009 to 2011
09 October 2014 - Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008-2011